InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,276.39
(
-0.68%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
85.01
(
0.37%
)
Bitcoin
64,954.38
(
-0.02%
)
Post# of 252275
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119882
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 228059

Thursday, 09/17/2020 9:46:21 AM

Thursday, September 17, 2020 9:46:21 AM

Post# of 252275
BMY settles Revlimid US-patent litigation with RDY:

https://finance.yahoo.com/news/bristol-myers-squibb-announces-settlement-105900202.html

RDY’s earliest US-launch date is undisclosed, but it’s later than the Mar 2022 launch date for Natco, the first generic-drug company to settle with BMY on the Revlimid patent.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up